RKLB
Rocket Lab USA, Inc.
RKLB offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
XYL
Xylem Inc.
XYL has the edge over RKLB overall, supported by stronger valuation and lower modeled downside.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
XYL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
XYL's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
XYL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 17x | $94.03 | — |
| Current | 21x | $94.03 | — |
| Cheap | 32x | $143 | +52% |
| Fair | 40x | $182 | +94% |
| Expensive | 62x | $278 | +196% |
Historical ranges are pointers, not guarantees.
XYL's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 17x next year's earnings.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RKLB has the edge over XYL on the outlook, with more favorable revenue expectations.
XYL Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect XYL's earnings to grow and its profitability to improve, with its revenue holding steady.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
XYL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.62 | +24% |
| Q3 2026 | $4.52 | +16% |
| Q2 2026 | $4.20 | +9.4% |
| Q1 2026 | $4.02 | +8.4% |
| Q4 2025 | $3.92 | +7.4% |
| Q3 2025 | $3.88 | +11% |
| Q2 2025 | $3.84 | +19% |
| Q1 2025 | $3.71 | +29% |
| Q4 2024 | $3.65 | +31% |
XYL has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over XYL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
XYL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | -3% |
| Q2 2026 | $2.3B | +1.5% |
| Q1 2026 | $2.1B | +2.7% |
| Q4 2025 | $2.4B | +6.3% |
| Q3 2025 | $2.3B | +7.8% |
| Q2 2025 | $2.3B | +6.1% |
| Q1 2025 | $2.1B | +1.8% |
| Q4 2024 | $2.3B | +6.5% |
XYL's revenue grew through 2024 and has held roughly level since: $2.2B last quarter, down 3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +2.8 points |
| Q2 2026 | 17% | +3.4 points |
| Q1 2026 | 11% | +0.3 points |
| Q4 2025 | 15% | +2.9 points |
| Q3 2025 | 15% | +1.4 points |
| Q2 2025 | 13% | +1.6 points |
| Q1 2025 | 11% | +0.9 points |
| Q4 2024 | 12% | +1.9 points |
XYL has the edge over RKLB on profitability, with a higher operating margin.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
XYL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $242M | -14% |
| Q2 2026 | $201M | -2.9% |
| Q1 2026 | $18M | +$56M |
| Q4 2025 | $460M | -3.2% |
| Q3 2025 | $281M | +19% |
| Q2 2025 | $207M | -3.7% |
| Q1 2025 | -$38M | -353% |
| Q4 2024 | $475M | +32% |
XYL has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
XYL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -3.5M shares |
| 1 year | -4.5% | -11.1M shares |
| 3 years | -3.8% | -9.1M shares |
| 5 years | +28% | +51.4M shares |
| Available history | +29% | +51.8M shares |
XYL has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $337M |
| Q2 2026 | $680M |
| Q1 2026 | $563M |
| Q4 2025 | $1M |
| Q3 2025 | $1M |
| Q2 2025 | — |
| Q1 2025 | $13M |
| Q4 2024 | $1M |
XYL spent $1.6B buying back its own shares over the past year, more than ten times what it spent the year before.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
XYL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.1x | Healthy |
| Q2 2026 | 0.9x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.6x | Very low |
XYL's net debt is about 1.1 years of its operating earnings (EBITDA), up from less than a year a year ago.
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
XYL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.6 | Neutral |
| Stochastic | 19.7 | Oversold |
XYL's weekly RSI is 35 (neutral) and its Stochastic is 20 (oversold).
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
XYL PE vs Industrials Sector
| Metric | XYL | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 24x | 14% below |
| PE % | 0 | 58 | 58 pts below |
XYL is trading at 21x earnings, a 14% discount to the Industrials sector's median of 24x.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over XYL on trend strength, trading above more of its moving averages.
XYL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $100.5 | 6.5% below |
| 20 week MA | $109.4 | 14% below |
| 50 week MA | $119.0 | 21% below |
| 100 week MA | $124.8 | 25% below |
| 200 week MA | $120.7 | 22% below |
XYL is in a downtrend: it's below all five of its weekly moving averages, and 22% below its 200-week average.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over XYL on returns for 2026, with the stronger performance.
XYL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $78.8 | $100.3 | +27% |
| 2021 | $100.3 | $117.5 | +17% |
| 2022 | $117.5 | $109.7 | -6.6% |
| 2023 | $109.7 | $114.4 | +4.2% |
| 2024 | $114.4 | $117.5 | +2.8% |
| 2025 | $117.5 | $138.8 | +18% |
| 2026 YTD | $138.8 | $94.0 | -32% |
XYL is down 32% so far in 2026, after finishing higher in five of the previous six years.